KUALA LUMPUR: Investors could be rushing to offload their holdings in glove stocks following news that Pfizer's Covid-19 vaccine trials have showed evidence of safe and effective inoculation against the virus.
"We already downgraded the glove sector to 'neutral from 'overweight' on 25 Aug 2020 on the back of positive news on vaccine development.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!